Benitec Biopharma Ltd ADR (BNTC)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jerel A. Banks
Employees:
20
3940 TRUST WAY, HAYWARD, CA, 94545
(510) 780-0819
-
Formally known as:
- BENITEC BIOP DRC
- Benitec Biopharma Inc.
- BENITEC BIOPHARMA LT (AUS)
- BENITEC BIOPHARMA LT (AUS)
- BENITEC BIOPHARMA LT (AUS)
- BENITEC BIOPHARMA LT (AUSTRALIA)
Date | Ratio |
---|---|
2015-06-16 | 1:4 |
2019-11-18 | 1:10 |
2020-04-15 | 2:3 |
2023-07-26 | 1:17 |
Benitec Biopharma focuses on the development of novel genetic medicines. The company is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. BB-103 for the treatment of chronic hepatitis B virus infection.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|